GFAP and Alzheimer disease: GFAP levels have recently been reported to be predictive of conversion of MCI to AD-dementia in several studies with steeper trends of conversion for cognitively abnormal groups (99, 100) and were able to discriminate between MCI individuals who progressed to dementia and non-progressors (101).